TEVA-CLINDAMYCIN dose modification may not be necessary in patients with renal disease. TEVA-CLINDAMYCIN dosage modification is not necessary in
Renal or hepatic impairment (See Renal Dosing Tables). The use of clindamycin, cephalosporins or co-amoxiclav are not recommended for the routine management of
clindamycin Dose Adjustment in Renal Impairment. February 2024: shortage of all forms of parenteral clindamycin; Use is reserved to
RIVA-CLINDAMYCIN dose modification may not be necessary in patients with renal disease. RIVA-. CLINDAMYCIN dosage modification is not necessary
clindamycin Dose Adjustment in Renal Impairment. February 2024: shortage of all forms of parenteral clindamycin; Use is reserved to
If a dose of Clindamycin Phosphate in Sodium Chloride Injection is Clindamycin dosage modification is not necessary in patients with renal disease.
Clindamycin. 167. Clobazam. 168. Clofazimine. 169 Dosing guidelines for varying degrees of renal impairment are stated accordingly. Dose in renal
JAMP Clindamycin dose modification may not be necessary in patients with renal disease. The serum half-life of clindamycin is increased slightly
RIVA-CLINDAMYCIN dose modification may not be necessary in patients with renal disease. RIVA-. CLINDAMYCIN dosage modification is not necessary
Comments